Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.7K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.7K
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

6.6K
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
6.6K
Imaging Studies for Cardiovascular System I:Echocardiography01:17

Imaging Studies for Cardiovascular System I:Echocardiography

987
Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
987
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

1.9K
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
1.9K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

719
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
719
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers01:27

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

1.7K
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anticoagulation risk assessment for patients with non-valvular atrial fibrillation and venous thromboembolism: A clinical review.

Vascular medicine (London, England)·2019
Same author

Health Factors Associated with Cardiovascular Wellness.

Current atherosclerosis reports·2019
Same author

Selective Use of Coronary Artery Calcium Testing for Shared Decision Making: Guideline Endorsed and Ready for Prime Time.

Annals of internal medicine·2019
Same author

How Low to Go With Lipid-Lowering Therapies in a Cost-effective and Prudent Manner.

Mayo Clinic proceedings·2019
Same author

Clinician's Guide to the Updated ABCs of Cardiovascular Disease Prevention: A Review Part 2.

The American journal of medicine·2019
Same author

Clinician's Guide to the Updated ABCs of Cardiovascular Disease Prevention: A Review Part 1.

The American journal of medicine·2019
Same journal

UK alcohol deaths: we know that minimum unit pricing works.

BMJ (Clinical research ed.)·2026
Same journal

Ebola control is weakened by mistrust and cultural insensitivity.

BMJ (Clinical research ed.)·2026
Same journal

Open letter to the Health and Safety Executive on work related suicides.

BMJ (Clinical research ed.)·2026
Same journal

The hand surgeon who sailed in the wake of Captain Cook.

BMJ (Clinical research ed.)·2026
Same journal

Cannibalism: scientists say it's bad for your health.

BMJ (Clinical research ed.)·2026
Same journal

Measurement of ethnicity in clinical trials: Delphi survey and consensus statement.

BMJ (Clinical research ed.)·2026
See all related articles

Related Experiment Video

Updated: Apr 26, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.8K

Non-cardiovascular effects associated with statins.

Chintan S Desai1, Seth S Martin2, Roger S Blumenthal2

  • 1Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Baltimore, MD 21287, USA cdesai6@jhmi.edu.

BMJ (Clinical Research Ed.)
|July 19, 2014
PubMed
Summary
This summary is machine-generated.

Statins are crucial for preventing cardiovascular disease, with most non-cardiovascular side effects like myopathy and diabetes being rare or manageable. Their cardiovascular benefits generally outweigh risks for high-risk patients.

More Related Videos

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

13.2K
An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

11.7K

Related Experiment Videos

Last Updated: Apr 26, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.8K
LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

13.2K
An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

11.7K

Area of Science:

  • Pharmacology
  • Cardiovascular Medicine
  • Clinical Therapeutics

Background:

  • Statins are primary and secondary prevention cornerstones for atherosclerotic cardiovascular disease.
  • While cardiovascular benefits are established, non-cardiovascular effects require careful consideration.
  • Concerns regarding hepatotoxicity and cancer have largely subsided, with focus shifting to myopathy and diabetes.

Purpose of the Study:

  • To review the non-cardiovascular effects of statins.
  • To assess the risks and benefits of statins beyond their cardiovascular impact.
  • To inform clinical practice regarding statin use and potential adverse events.

Main Methods:

  • Systematic review of randomized controlled trials and meta-analyses.
  • Analysis of evidence regarding myopathy, diabetes, contrast-induced nephropathy, cognition, cataracts, erectile dysfunction, and venous thromboembolism.
  • Evaluation of current clinical practice guidelines and systematic reviews.

Main Results:

  • Statins show a modest increase in myositis risk, but not myalgia; severe myopathy (rhabdomyolysis) is rare.
  • An increased risk of diabetes is associated with statins, especially higher-intensity regimens in metabolic syndrome patients.
  • Cardiovascular benefits of statins generally outweigh non-cardiovascular harms for patients above a defined cardiovascular risk threshold.

Conclusions:

  • The cardiovascular benefits of statins typically outweigh non-cardiovascular risks in appropriate patient populations.
  • Emerging evidence suggests potential non-cardiovascular benefits of statins, opening avenues for future therapeutic applications.
  • Clinicians should weigh cardiovascular risk against potential non-cardiovascular effects when prescribing statins.